GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start
Public ClinicalTrials.gov record NCT01191385. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Non Interventional Study in Patients With Diagnosis of HCC in Whom a Decision to Treat With Sorafenib Has Not Been Made at Time of Study Enrollment
Study identification
- NCT ID
- NCT01191385
- Recruitment status
- Withdrawn
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Bayer
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Any treatment for unresectable HCC as chosen by the physician Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2010
- Primary completion
- Nov 30, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Aug 15, 2017
2010 – 2013
United States locations
- U.S. sites
- 24
- U.S. states
- 24
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Multiple Locations | Arkansas | — | — |
| Not listed | Multiple Locations | California | — | — |
| Not listed | Multiple Locations | Colorado | — | — |
| Not listed | Multiple Locations | District of Columbia | — | — |
| Not listed | Multiple Locations | Florida | — | — |
| Not listed | Multiple Locations | Georgia | — | — |
| Not listed | Multiple Locations | Illinois | — | — |
| Not listed | Multiple Locations | Indiana | — | — |
| Not listed | Multiple Locations | Iowa | — | — |
| Not listed | Multiple Locations | Kentucky | — | — |
| Not listed | Multiple Locations | Louisiana | — | — |
| Not listed | Multiple Locations | Maryland | — | — |
| Not listed | Multiple Locations | Massachusetts | — | — |
| Not listed | Multiple Locations | Michigan | — | — |
| Not listed | Multiple Locations | Minnesota | — | — |
| Not listed | Multiple Locations | Missouri | — | — |
| Not listed | Multiple Locations | New Hampshire | — | — |
| Not listed | Multiple Locations | New Jersey | — | — |
| Not listed | Multiple Locations | New York | — | — |
| Not listed | Multiple Locations | Oregon | — | — |
| Not listed | Multiple Locations | Pennsylvania | — | — |
| Not listed | Multiple Locations | South Carolina | — | — |
| Not listed | Multiple Locations | Texas | — | — |
| Not listed | Multiple Locations | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01191385, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2017 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01191385 live on ClinicalTrials.gov.